Rhumbline Advisers Omnicell, Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Omnicell, Inc stock. As of the latest transaction made, Rhumbline Advisers holds 142,458 shares of OMCL stock, worth $6.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
142,458
Previous 147,188 3.21%
Holding current value
$6.15 Million
Previous $3.98 Million 55.9%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$25.61 - $45.43 $121,135 - $214,883
-4,730 Reduced 3.21%
142,458 $6.21 Million
Q2 2024

Aug 01, 2024
BUY
$26.22 - $32.65 $112,247 - $139,774
4,281 Added 3.0%
147,188 $3.98 Million
Q1 2024

May 09, 2024
BUY
$26.15 - $37.33 $5,491 - $7,839
210 Added 0.15%
142,907 $4.18 Million
Q4 2023

Feb 08, 2024
SELL
$29.24 - $45.81 $95,322 - $149,340
-3,260 Reduced 2.23%
142,697 $5.37 Million
Q3 2023

Nov 09, 2023
SELL
$44.6 - $73.38 $428,070 - $704,301
-9,598 Reduced 6.17%
145,957 $6.57 Million
Q2 2023

Aug 08, 2023
BUY
$57.88 - $75.94 $348,784 - $457,614
6,026 Added 4.03%
155,555 $11.5 Million
Q1 2023

May 11, 2023
BUY
$51.51 - $60.43 $463 - $543
9 Added 0.01%
149,529 $8.77 Million
Q4 2022

Feb 14, 2023
BUY
$46.24 - $90.03 $445,938 - $868,249
9,644 Added 6.89%
149,520 $7.54 Million
Q3 2022

Nov 10, 2022
BUY
$84.23 - $117.38 $2 Million - $2.79 Million
23,776 Added 20.48%
139,876 $12.2 Million
Q2 2022

Aug 11, 2022
BUY
$105.64 - $129.11 $528,411 - $645,808
5,002 Added 4.5%
116,100 $13.2 Million
Q1 2022

May 12, 2022
BUY
$120.68 - $180.51 $803,366 - $1.2 Million
6,657 Added 6.37%
111,098 $14.4 Million
Q4 2021

Feb 10, 2022
SELL
$153.26 - $183.62 $158,011 - $189,312
-1,031 Reduced 0.98%
104,441 $18.8 Million
Q3 2021

Nov 12, 2021
SELL
$141.84 - $160.88 $2.31 Million - $2.62 Million
-16,301 Reduced 13.39%
105,472 $15.7 Million
Q2 2021

Aug 05, 2021
SELL
$129.91 - $151.45 $238,774 - $278,365
-1,838 Reduced 1.49%
121,773 $18.4 Million
Q1 2021

May 06, 2021
BUY
$117.78 - $143.9 $144,987 - $177,140
1,231 Added 1.01%
123,611 $16.1 Million
Q4 2020

Feb 10, 2021
BUY
$73.85 - $120.02 $225,242 - $366,061
3,050 Added 2.56%
122,380 $14.7 Million
Q3 2020

Nov 12, 2020
SELL
$63.15 - $77.12 $873,175 - $1.07 Million
-13,827 Reduced 10.38%
119,330 $8.91 Million
Q2 2020

Aug 13, 2020
SELL
$59.36 - $74.43 $270,740 - $339,475
-4,561 Reduced 3.31%
133,157 $9.4 Million
Q1 2020

May 06, 2020
BUY
$55.41 - $90.19 $174,098 - $283,376
3,142 Added 2.33%
137,718 $9.03 Million
Q4 2019

Feb 05, 2020
BUY
$70.15 - $83.11 $684,243 - $810,654
9,754 Added 7.81%
134,576 $11 Million
Q3 2019

Oct 23, 2019
BUY
$68.36 - $88.34 $271,867 - $351,328
3,977 Added 3.29%
124,822 $9.02 Million
Q2 2019

Aug 14, 2019
BUY
$71.38 - $92.21 $338,698 - $437,536
4,745 Added 4.09%
120,845 $10.4 Million
Q1 2019

May 01, 2019
BUY
$58.88 - $86.19 $177,994 - $260,552
3,023 Added 2.67%
116,100 $9.39 Million
Q4 2018

Jan 31, 2019
BUY
$56.97 - $77.23 $1.11 Million - $1.51 Million
19,544 Added 20.9%
113,077 $6.93 Million
Q3 2018

Nov 07, 2018
SELL
$52.65 - $71.9 $114,513 - $156,382
-2,175 Reduced 2.27%
93,533 $6.73 Million
Q2 2018

Aug 06, 2018
BUY
$42.2 - $53.05 $134,027 - $168,486
3,176 Added 3.43%
95,708 $5.02 Million
Q1 2018

May 02, 2018
BUY
$40.1 - $52.45 $175,597 - $229,678
4,379 Added 4.97%
92,532 $4.02 Million
Q4 2017

Feb 09, 2018
BUY
$45.3 - $54.5 $568,197 - $683,593
12,543 Added 16.59%
88,153 $4.28 Million
Q3 2017

Nov 06, 2017
BUY
$48.1 - $52.15 $3.64 Million - $3.94 Million
75,610
75,610 $3.86 Million

Others Institutions Holding OMCL

# of Institutions
276
Shares Held
44.3M
Call Options Held
224K
Put Options Held
35.7K
View Full List

About OMNICELL, Inc

OMCL Quotes by TradingView
  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $1.91B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email